The European Union will impose a ban starting Aug. 21 on more than 700 drugs that were bioequivalency tested by India's GVK BioSciences after inspectors raised questions about its procedures. India has tried to intercede but, according to a posting by German regulators, the ban will move forward and include drugs sold by both Indian and multinational companies and will apply to all 28 EU countries. More from FiercePharmaAsia | More